Remove 2000 Remove Microdosing Remove Patients
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009. Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers.